Effects of combined treatment of minocycline and methylprednisolone on the expression of tumor necrosis factor alpha and interleukine-6 in experimental spinal cord injury: a light and electron microscopic study. (3rd May 2020)
- Record Type:
- Journal Article
- Title:
- Effects of combined treatment of minocycline and methylprednisolone on the expression of tumor necrosis factor alpha and interleukine-6 in experimental spinal cord injury: a light and electron microscopic study. (3rd May 2020)
- Main Title:
- Effects of combined treatment of minocycline and methylprednisolone on the expression of tumor necrosis factor alpha and interleukine-6 in experimental spinal cord injury: a light and electron microscopic study
- Authors:
- Sencar, Leman
Yilmaz, Derviş Mansuri
Tuli, Abdullah
Polat, Sait - Abstract:
- ABSTRACT: Spinal cord injury (SCI) is an important health problem, and there is no universal treatment protocol for it today. Following SCI pro-inflammatory mediators such as tumor necrosis factor- alpha (TNF-α) and interleukin-6 (IL-6) increase at the lesion site and play important roles in secondary tissue damage. Methylprednisolone (MP) is a glucocorticoid, and minocycline is a tetracycline-derived antibiotic both with neuroprotective effects on central nervous system trauma. However, there are limited studies on their effects on SCI. In this study, we aimed to evaluate effects of MP+minocycline combined treatment on cellular distribution and localization of TNF-α And IL-6 after SCI. Eighty Wistar rats were divided into three main groups as the intact control group, sham operation group, and experimental control group that received spinal cord compression injury. Following the injury, the experimental control group was subdivided into four groups as control, methylprednisolone treatment, minocycline treatment and, MP+minocycline combined treatment groups. Tissue samples were obtained from all groups at 24 hours and 72 hours after the injury. We found a significant decrease in TNF-α And IL-6 expressions in combined treatment group at 24 hours after injury. Also, there was a significant decrease in MDA and increase in SOD levels in this group. Furthermore, decreased lipid peroxidation and neuronal and glial cell death were also observed in combined treatment group. TheseABSTRACT: Spinal cord injury (SCI) is an important health problem, and there is no universal treatment protocol for it today. Following SCI pro-inflammatory mediators such as tumor necrosis factor- alpha (TNF-α) and interleukin-6 (IL-6) increase at the lesion site and play important roles in secondary tissue damage. Methylprednisolone (MP) is a glucocorticoid, and minocycline is a tetracycline-derived antibiotic both with neuroprotective effects on central nervous system trauma. However, there are limited studies on their effects on SCI. In this study, we aimed to evaluate effects of MP+minocycline combined treatment on cellular distribution and localization of TNF-α And IL-6 after SCI. Eighty Wistar rats were divided into three main groups as the intact control group, sham operation group, and experimental control group that received spinal cord compression injury. Following the injury, the experimental control group was subdivided into four groups as control, methylprednisolone treatment, minocycline treatment and, MP+minocycline combined treatment groups. Tissue samples were obtained from all groups at 24 hours and 72 hours after the injury. We found a significant decrease in TNF-α And IL-6 expressions in combined treatment group at 24 hours after injury. Also, there was a significant decrease in MDA and increase in SOD levels in this group. Furthermore, decreased lipid peroxidation and neuronal and glial cell death were also observed in combined treatment group. These results suggest that MP+minocycline combined treatment promotes functional recovery and, it should be considered as an effective treatment protocol following SCI. … (more)
- Is Part Of:
- Ultrastructural pathology. Volume 44:Number 3(2020)
- Journal:
- Ultrastructural pathology
- Issue:
- Volume 44:Number 3(2020)
- Issue Display:
- Volume 44, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 44
- Issue:
- 3
- Issue Sort Value:
- 2020-0044-0003-0000
- Page Start:
- 283
- Page End:
- 299
- Publication Date:
- 2020-05-03
- Subjects:
- IL-6 -- methylprednisolone -- minocycline -- spinal cord injury -- TNF-α -- ultrastructure
Pathology, Cellular -- Periodicals
Ultrastructure (Biology) -- Periodicals
Diagnosis, Electron microscopic -- Periodicals
Microscopy, Electron
Pathology
616.07582 - Journal URLs:
- http://informahealthcare.com/loi/usp ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/01913123.2020.1771493 ↗
- Languages:
- English
- ISSNs:
- 0191-3123
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9082.816000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22471.xml